BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 463954)

  • 1. Human chorionic gonadotropin beta-subunit--like immunoreactive material in the plasma of women wearing an intrauterine progesterone contraceptive system.
    Orloff VS; Yamamoto S; Greenwood FC; Bryant-Greenwood GD
    Am J Obstet Gynecol; 1979 Jul; 134(6):632-7. PubMed ID: 463954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
    Klein TA; Mishell DR
    Am J Obstet Gynecol; 1977 Nov; 129(6):626-8. PubMed ID: 920763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
    Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
    Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
    Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human chorionic gonadotropin in intrauterine device users.
    Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
    Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of chorionic gonadotrophin like activity in infertile cycles with a short luteal phase.
    Seppälä M; Lehtovirta P; Rutanen EM
    Acta Endocrinol (Copenh); 1978 May; 88(1):164-8. PubMed ID: 580531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of HCG in subjects using the Progestasert(TM) intrauterine progesterone systems.
    Custo GM; Carenza L; Pala A
    Contraception; 1980 Mar; 21(3):311-7. PubMed ID: 6771092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal evaluation of the intrauterine progesterone contraceptive system.
    Bryand-Greenwood GD; Greenwood FC; Hale RW; Morishige WK
    J Clin Endocrinol Metab; 1977 Apr; 44(4):721-7. PubMed ID: 849982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Int J Fertil; 1979; 24(2):134-7. PubMed ID: 40908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of hCG-like activity in the blood of women fitted with intra-uterine contraceptive devices.
    Sharpe RM; Wrixon W; Hobson BM; Corker CS; McLean HA; Short RV
    J Clin Endocrinol Metab; 1977 Sep; 45(3):496-9. PubMed ID: 903400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of elevated circulating levels of LH during the pre-menstrual period in some copper IUD users and the possibility of their confusion with hCG.
    Dattatreyamurty B; Joshi J; Mehta S; Virkar KD; Sheth AR
    Contraception; 1979 Mar; 19(3):213-21. PubMed ID: 455978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of plasma human chorionic gonadotropin (hCG) and beta-hCG activities in the late luteal phase: evidence of the occurrence of spontaneous menstrual abortions in infertile women.
    Chartier M; Roger M; Barrat J; Michelon B
    Fertil Steril; 1979 Feb; 31(2):134-7. PubMed ID: 761674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily serum choriogonadotropin concentrations in early human gestation.
    Adejuwon CA; Alvarez F; Segal SJ; Faundes A
    Int J Gynaecol Obstet; 1984 Apr; 22(2):125-9. PubMed ID: 6145636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norplant implants: the mechanism of contraceptive action.
    Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human chorionic gonadotropin in blood of regularly bleeding women using copper intrauterine contraceptive devices.
    Landesman R; Coutinho EM; Saxena BB
    Fertil Steril; 1976 Sep; 27(9):1062-6. PubMed ID: 964399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
    Fogel M; Rubin BL; Ossowski R
    Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of human chorionic gonadotropin during the second half of the menstrual cycle in plasma of regularly menstruating women users of copper IUds.
    Capitanio GL; Conte N; Ragni N; Rossato P; Pedretti E
    Acta Eur Fertil; 1978 Mar; 9(1):11-9. PubMed ID: 696185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.